These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 533264)

  • 1. Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination.
    Felegie TP; Yu VL; Rumans LW; Yee RB
    Antimicrob Agents Chemother; 1979 Dec; 16(6):833-7. PubMed ID: 533264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro sensitivity of Salmonella to ten antimicrobial agents including sulfamethoxazole and trimethoprim, alone and in combination.
    Marks MI; Kazemi M; MacKay E
    Antimicrob Agents Chemother; 1973 Nov; 4(5):555-9. PubMed ID: 4791490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia.
    Yu VL; Felegie TP; Yee RB; Pasculle AW; Taylor FH
    J Infect Dis; 1980 Oct; 142(4):602-7. PubMed ID: 7441019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
    Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
    J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Pseudomonas species to carbenicillin and trimethoprim-sulfamethoxazole.
    Hill SF; Haldane DJ; Ngui-Yen JH; Smith JA
    J Clin Microbiol; 1985 Sep; 22(3):465-6. PubMed ID: 3930567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
    Biagi M; Vialichka A; Jurkovic M; Wu T; Shajee A; Lee M; Patel S; Mendes RE; Wenzler E
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
    Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimicrobial susceptibility patterns of clinical isolates of Pseudomonas cepacia (author's transl)].
    Igari J; Kosakai N; Oguri T
    Jpn J Antibiot; 1979 Oct; 32(10):998-1002. PubMed ID: 259663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of antimicrobials against
    Spierer O; Miller D; O'Brien TP
    Br J Ophthalmol; 2018 May; 102(5):708-712. PubMed ID: 29459431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
    Wei C; Ni W; Cai X; Zhao J; Cui J
    PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia.
    Nord CE; Wadström T; Wretlind B
    Antimicrob Agents Chemother; 1974 Oct; 6(4):521-3. PubMed ID: 4143759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia.
    Liaw SJ; Teng LJ; Hsueh PR; Ho SW; Luh KT
    J Formos Med Assoc; 2002 Jul; 101(7):495-501. PubMed ID: 12353342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy of azlocillin with aminoglycosides.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():33-8. PubMed ID: 6413482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new).
    Yu VL; Vickers RM; Zuravleff JJ
    Antimicrob Agents Chemother; 1980 Jan; 17(1):96-8. PubMed ID: 6766295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
    Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
    J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Infection; 1982; 10 Suppl 3():S257-61. PubMed ID: 6818158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
    Crider SR; Colby SD
    Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):511-8. PubMed ID: 791104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
    Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC
    J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
    Marks MI; Hammerberg S; Greenstone G; Silver B
    Antimicrob Agents Chemother; 1976 Sep; 10(3):399-401. PubMed ID: 825026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.